Suchergebnisse - "Nakagawa, Hidemi"

PubPharm (429)

1

Safety, efficacy, and pharmacokinetics of delgocitinib ointment in infants with atopic dermatitis : A phase 3, open-label, and long-term study

enthalten in: Allergology international : official journal of the Japanese Society of Allergology | 2024

von Nakagawa, H. | Igarashi, A. | Saeki, H. | +4

2

Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID : A Phase 3, Ustekinumab and Placebo-Controlled Study

enthalten in: Dermatology and therapy | 2023

von Asahina, A. | Okubo, Y. | Morita, A. | +9

3

Generation of induced pluripotent stem cell (iPSC) from NY-ESO-I-specific cytotoxic T cells isolated from the melanoma patient with minor HLAs : The practical pilot study for the adoptive immunotherapy for melanoma using iPSC technology

enthalten in: Experimental dermatology | 2023

von Itoh, M. | Kawagoe, S. | Nakagawa, H. | +2

4

Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study

enthalten in: Dermatology and therapy | 2023

von Asahina, A. | Okubo, Y. | Morita, A. | +9

5

Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study

enthalten in: Dermatology and therapy | 2023

von Asahina, A. | Okubo, Y. | Morita, A. | +9

6

Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study

enthalten in: Dermatology and therapy | 2023

von Asahina, A. | Okubo, Y. | Morita, A. | +9

7

METHOD FOR TREATING PSORIASIS PATIENT WHICH RECEIVED ANTI-TNF-ALPHA ANTIBODY THERAPY

enthalten in: Europäisches Patentamt | 2022

von NAKAGAWA HIDEMI | MATSUDO HIROKI

8

METHODS OF TREATING NAIL AND SCALP PSORIASIS

enthalten in: Europäisches Patentamt | 2022

von NIRULA AJAY | NAKAGAWA HIDEMI | OHTAKI KENJI | +3

9

Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis : 52-Week Results

enthalten in: Dermatology and therapy | 2022

von Okubo, Y. | Umezawa, Y. | Sakurai, S. | +2

10

Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results

enthalten in: Dermatology and therapy | 2022

von Okubo, Y. | Umezawa, Y. | Sakurai, S. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[43]